News Releases

Leading New Gene-based Therapies


Enochian Biosciences Announces Scientific Presentation of a Novel Approach to Potentially Cure Hepatitis B Virus

December 10, 2019


Enochian Biosciences Expands its Infectious Disease Pipeline by Entering into an Agreement in Principle to Acquire an Exclusive License for a Novel Hepatitis B Virus Treatment

November 25, 2019


Enochian BioSciences Inventor Named to Two Important Scientific Committees

June 3, 2019


Enochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-Chair

January 7, 2019


Enochian Biosciences Announces Uplisting to NASDAQ Under Symbol “ENOB”

December 5, 2018


Enochian Biosciences Attending 60th ASH on Nov 30-Dec 4 in San Diego, CA

November 27, 2018


Enochian Biosciences to Present at Biotech Showcase 2019

November 23, 2018


Enochian Biosciences Attending Cell & Gene Meeting on the Mesa on October 3-5, 2018 in La Jolla, California.

September 4, 2018


Enochian Biosciences Announces Appointment of Dr. David Hardy to Scientific Advisory Board

July 3, 2018


Dandrit Biotech announces filing of listing application to the Nasdaq capital market

February 23, 2018


Dandrit Biotech announces completion of the acquisition of Enochian

February 20, 2018


Dandrit Biotech announces acquisition of Enochian New York, NY

January 17, 2018